Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001193125-06-047210
Filing Date
2006-03-07
Accepted
2006-03-07 16:33:54
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/T d10kt.htm 10-KT 1276451
2 LETTER RE CHANGE IN ACCOUNTING PRINCIPLES dex181.htm EX-18.1 3316
3 SUBSIDIARIES OF ALEXION PHARMACEUTICALS, INC dex211.htm EX-21.1 916
4 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1759
5 CERTIFICATE OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9333
6 CERTIFICATE OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 4292
7 CERTIFICATE OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 9331
8 CERTIFICATE OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 4217
9 GRAPHIC g97648g18g82.jpg GRAPHIC 23398
  Complete submission text file 0001193125-06-047210.txt   1343384
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

EIN.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 000-27756 | Film No.: 06670494
SIC: 2834 Pharmaceutical Preparations